Effectiveness of COVID-19 Vaccination against Severe Symptoms and Death Among Geriatric Inpatients: A Retrospective Cohort Study in Macao
- PMID: 39204056
- PMCID: PMC11359226
- DOI: 10.3390/vaccines12080933
Effectiveness of COVID-19 Vaccination against Severe Symptoms and Death Among Geriatric Inpatients: A Retrospective Cohort Study in Macao
Abstract
Monitoring the effectiveness of COVID-19 vaccination is critical for understanding if the vaccinated population, especially the elderly, is adequately protected from the emergence of new SARS-CoV-2 variants. This study aimed to investigate the effects of COVID-19 vaccination on the severity of symptoms and mortality in hospitalized geriatric patients during the Omicron BF.7 surge in Macao. Data from electronic health records and vaccination registry of inpatients aged 60 years or above admitted to Kiang Wu Hospital from 12 December 2022 to 12 March 2023 were retrospectively analyzed. The study involved 848 people, including 426 vaccinated and 422 unvaccinated individuals. The mean CXR scores (8.95 ± 9.49 vs. 11.41 ± 10.81, p < 0.001) and the mean MEWS scores (0.96 ± 2.01 vs. 1.49 ± 2.45, p < 0.001) were lower in the vaccinated group. By comparing the dose counts, no significant difference was seen in the odds of death. Based on the time of the last vaccination, 128 people were categorized as complete and 298 as incomplete vaccination. The complete vaccination group showed a 54% (95% CI 0.23-0.91) reduction in mortality risk (p = 0.026). The study findings not only reconfirm the effectiveness of COVID-19 vaccination but, more importantly, highlight the importance of vaccination timing to maximize vaccines' protective effect.
Keywords: COVID-19 vaccines; Omicron BF.7; SARS-CoV-2 variants; elderly; geriatrics; mortality; vaccination timing; vaccine effectiveness.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study.Lancet Diabetes Endocrinol. 2022 Aug;10(8):571-580. doi: 10.1016/S2213-8587(22)00158-9. Epub 2022 Jul 1. Lancet Diabetes Endocrinol. 2022. PMID: 35780805 Free PMC article.
-
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9. J Med Virol. 2022. PMID: 36029103 Free PMC article.
-
Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.JAMA Netw Open. 2022 Oct 3;5(10):e2238871. doi: 10.1001/jamanetworkopen.2022.38871. JAMA Netw Open. 2022. PMID: 36301541 Free PMC article.
-
Effect of inactivated vaccine boosters against severe and critical COVID-19 during the Omicron BA.5 wave: A retrospective analysis of hospitalized patients in China.J Med Virol. 2024 Feb;96(2):e29402. doi: 10.1002/jmv.29402. J Med Virol. 2024. PMID: 38380744
-
Beyond prevention: Unveiling the benefits of triple vaccination on COVID-19 severity and resource utilization in solid organ transplant recipients.Transpl Immunol. 2024 Jun;84:102048. doi: 10.1016/j.trim.2024.102048. Epub 2024 Apr 17. Transpl Immunol. 2024. PMID: 38641149
Cited by
-
Assessment of COVID-19 Vaccine Effectiveness Against SARS-CoV-2 Infection, Hospitalization and Death in Mexican Patients with Metabolic Syndrome from Northeast Mexico: A Multicenter Study.Vaccines (Basel). 2025 Feb 27;13(3):244. doi: 10.3390/vaccines13030244. Vaccines (Basel). 2025. PMID: 40266114 Free PMC article.
References
-
- World Health Organization WHO COVID-19 Dashboard—Number of COVID-19 Deaths Reported to WHO (Cumulative Total) [(accessed on 20 July 2024)]. Available online: https://data.who.int/dashboards/covid19/deaths?n=c.
-
- World Health Organization The Different Types of COVID-19 Vaccines. [(accessed on 20 July 2024)]. Available online: https://www.who.int/news-room/feature-stories/detail/the-race-for-a-covi....
-
- The Food and Drug Administration FDA Approves First COVID-19 Vaccine. [(accessed on 20 July 2024)]; Available online: https://www.fda.gov/news-events/press-announcements/fda-approves-first-c....
-
- Tartof S.Y., Slezak J.M., Fischer H., Hong V., Ackerson B.K., Ranasinghe O.N., Frankland T.B., Ogun O.A., Zamparo J.M., Gray S., et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. Lancet. 2021;398:1407–1416. doi: 10.1016/s0140-6736(21)02183-8. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous